ストックスクリーナーアプリを入手
1.53
6.25%
0.09
アフターアワーズ：
1.57
0.04
+2.61%
前日終値:
$1.44
開ける：
$1.49
24時間の取引高:
927.00K
Relative Volume:
4.06
時価総額：
$126.45M
収益：
-
当期純損益:
$-21.65M
株価収益率:
-4.607
EPS:
-0.3321
ネットキャッシュフロー:
$-15.84M
1週間 パフォーマンス:
+25.41%
1か月 パフォーマンス:
+8.51%
6か月 パフォーマンス:
+16.79%
1年 パフォーマンス:
-32.00%
1日の値動き範囲:
$1.40
$1.59
1週間の範囲:
$1.23
$1.59
52週間の値動き範囲:
$0.7709
$2.63
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
CRDL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.53 | 119.02M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
150.75 | 67.73B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.31 | 45.73B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.70 | 44.38B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.51 | 18.97B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
298.14 | 13.73B | 2.99B | 1.21B | 1.13B | 25.06 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-02 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
| 2024-06-26 | 開始されました | ROTH MKM | Buy |
| 2024-04-22 | 開始されました | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc (CRDL) 最新ニュース
What makes Cardiol Therapeutics Inc. stock price move sharplyMulti-Year Investment Performance Summary Report - Newser
Chart based analysis of Cardiol Therapeutics Inc. trendsVolume Confirmed Setup with Entry Confidence - Newser
Will Cardiol Therapeutics Inc. rebound enough to break evenAlpha Stock Picks with Chart Confirmation - Newser
Visualizing Cardiol Therapeutics Inc. stock with heatmapsAI Powered Stock Market Trend Forecast - Newser
Analyzing drawdowns of Cardiol Therapeutics Inc. with statistical toolsTechnical Analysis of Growth Stock Opportunities - Newser
How to integrate Cardiol Therapeutics Inc. into portfolio analysis toolsProfitable Trading Blueprint with Entry Zones - Newser
Real time alert setup for Cardiol Therapeutics Inc. performance Entry Confirmation Based on Volatility Analysis - Newser
How to integrate Cardiol Therapeutics Inc. into portfolio analysis tools Watchlist Generator for Smart Money Signals - Newser
When is Cardiol Therapeutics Inc. stock expected to show significant growthAccelerate your capital gains today - jammulinksnews.com
Why is Cardiol Therapeutics Inc. stock attracting strong analyst attentionHigh-profit trading signals - jammulinksnews.com
How does Cardiol Therapeutics Inc. compare to its industry peersDiscover stocks with strong growth potential - jammulinksnews.com
Moving Average Trends for Cardiol Therapeutics Inc. Stock: What They IndicateReal Trader Insights - Newser
Why Cardiol Therapeutics Inc. stock attracts strong analyst attentionStable Growth Stock Picks - Newser
Is Cardiol Therapeutics Inc. Stock a Good Fit for Conservative InvestorsHigh Potential Shares - Newser
Published on: 2025-07-27 15:05:27 - jammulinksnews.com
How strong is Cardiol Therapeutics Inc. company’s balance sheetMaximize your portfolio’s earning potential - jammulinksnews.com
What drives Cardiol Therapeutics Inc. stock priceFree Stock Selection - PrintWeekIndia
Does Cardiol Therapeutics Inc. stock pay reliable dividendsSkyrocketing profit margins - jammulinksnews.com
How high can Cardiol Therapeutics Inc. stock price go in 2025Rapidly expanding wealth - jammulinksnews.com
Is Cardiol Therapeutics Inc. stock a good hedge against inflationSuperior risk-adjusted returns - jammulinksnews.com
Where are the Opportunities in (CRDL) (CRDL:CA) - news.stocktradersdaily.com
What analysts say about Cardiol Therapeutics Inc. stockSuperior stock growth - Autocar Professional
Cardiol Therapeutics stock holds Buy rating at H.C. Wainwright after trial update - Investing.com Canada
Cardiol Therapeutics Achieves Database Lock in ARCHER Trial for Acute Myocarditis - MSN
Is Cardiol Therapeutics Inc. a good long term investmentTriple-digit profit margins - jammulinksnews.com
Cardiol rises on database lockup for acute myocarditis therapy trial - Seeking Alpha
Cardiol To Report ARCHER Study Data Within The Next Two Weeks - Nasdaq
Cardiol Therapeutics Announces Database Lock for Phase II ARCHER - GuruFocus
Cardiol Therapeutics announces database lock for myocarditis trial By Investing.com - Investing.com Nigeria
Cardiol Therapeutics announces database lock for myocarditis trial - Investing.com Australia
Breakthrough Acute Myocarditis Drug Trial Locks Database, Results Due in 2 Weeks - Stock Titan
Cardiol Therapeutics Inc. Stock Analysis and ForecastFastest-growing stock picks - jammulinksnews.com
(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics Inc (CRDL) 財務データ
収益
当期純利益
現金流量
EPS
0.71%
0.20%
大文字化:
|
ボリューム (24 時間):